Executive Team

Peter R. Lamptey, MD, DrPH, MPH

Distinguished Scientist and President Emeritus

Areas of expertise

  • International public health
  • Communicable and noncommunicable diseases
  • HIV prevention, care, treatment and support

Dr. Peter R. Lamptey is a public health physician and expert on health and development in developing countries, with particular expertise in communicable and noncommunicable diseases. Throughout his more than 30 year career at FHI 360, he has played a pivotal role in establishing the organization as a leader in implementing HIV/AIDS prevention, care, treatment and support programs.

From 1987 to 2007, Lamptey directed several key projects funded by the U.S. Agency for International Development (USAID), encompassing HIV/AIDS programs in more than 65 countries in Africa, Asia, Eastern Europe, Latin America and the Caribbean, and the Middle East. Lamptey serves on the CSIS Commission on Smart Global Health Policy and is a member of the Lancet Commission on Future Health of Sub-Saharan Africa. He is also a member of the Network of African Science Academies Committee on the Negative Effects of Tobacco on Africa’s Health, Economy, and Development and was formerly a member of the Institute of Medicine’s Committee on Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health.

Lamptey also worked on a USAID-funded Danfa Comprehensive Rural Health Family Planning Project (1973–1976), which was implemented by the University of California, Los Angeles (UCLA) and the University of Ghana Medical School. Born in Ghana, he received his medical degree from the University of Ghana, a master’s degree in public health from UCLA and a doctorate in public health from the Harvard School of Public Health. Lamptey is a Professor of Non-communicable Diseases and a member of the Global NCD Advisory Group at the London School of Hygiene and Tropical Medicine.

Projects & Resources

  • The Abundant Health project is a community-based prevention and control program targeting hypertension and diabetes in five locations in the Tan Phu District in Ho Chi Minh City, Vietnam.

  • FHI 360 is conducting monitoring and evaluation (M&E) to measure the impact of Avahan — the India AIDS Initiative.

Explore More Related to Peter R. Lamptey, MD, DrPH, MPH